Earnings History Data for Replimune Group, Inc. (REPL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Replimune Group, Inc.
Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2023 | PM | REPL | Replimune Group | 838.00 | -0.90 | -0.80 | 0.00 | Replimune Group GAAP EPS of -$0.90 misses by $0.04 [11/7/2023 8:22 AM] |
10.82 | -2.05 (-15.93%) |
13.44 | 0.57 (4.43%) |
10.79 - 29.52 | 1,075,327 | 610,000 | 5,110 | ||
| 04-08-2022 | PM | REPL | Replimune Group | 988.00 | -0.78 | -0.63 | 0.00 | Replimune Group GAAP EPS of -$0.78 misses by $0.15 [8/4/2022 8:49 AM] |
20.38 | -0.11 (-0.54%) |
20.29 | -0.20 (-0.98%) |
13.05 - 36.97 | 87,325 | 140,000 | 700 | ||
| 20-05-2021 | PM | REPL | Replimune Group, Inc. | 1,676 | -0.41 | -0.41 | 0.00 | Replimune Group EPS beats by $0.01 [5/20/2021 9:41 AM] |
35.93 | 1.65 (4.81%) |
35.00 | 0.72 (2.10%) |
17.50 - 54.85 | 157,454 | 260,000 | 39,188 | ||
| 04-02-2021 | PM | 8:00 AM ET (Feb 4) |
REPL | Replimune Group, Inc. | 1,867 | -0.44 | -0.41 | 0.00 | Replimune Group EPS misses by $0.03 [2/4/2021 8:18 AM] |
41.20 | 2.74 (7.12%) |
0.0 | 0.0 (0.00%) |
8.58 - 54.85 | 306,598 | 421,896 | 0 | |